Literature DB >> 1314108

Liveborn children and risk of hepatocellular carcinoma.

A Tzonou1, X Zavitsanos, C C Hsieh, D Trichopoulos.   

Abstract

Clinical, animal, and epidemiologic evidence indicates that exogenous steroids influence the risk of hepatocellular carcinoma (HCC) and a recent study suggested that parity also may increase the risk of this tumor in women. The latter hypothesis was evaluated in the data from a case-control study which was carried out in Athens and covered 166 male and 19 female cases of HCC, and 381 male and 51 female hospital controls. Among males, there was no association between the number of liveborn children and risk of HCC, whereas among women, there was a suggestive positive association. Compared with women with one or two children, the relative risk for HCC was 0.6 among nulliparous women, 1.3 among those with three or four children and 1.7 among those with five or more children. The association of parity with risk of HCC was limited to women who were positive for hepatitis-B surface antigen (HBsAg) and was not confounded by hepatitis-C virus infection or tobacco smoking. The small number of HCC cases does not permit firm conclusions. If confirmed, however, these results would provide the foundation for a practical preventive advice that could be given to women who are positive for HBsAg.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314108     DOI: 10.1007/bf00051657

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  19 in total

Review 1.  Estrogens and progestins as tumor inducers.

Authors:  L E Porter; D H Van Thiel; P K Eagon
Journal:  Semin Liver Dis       Date:  1987-02       Impact factor: 6.115

2.  A study of cancer, parity and age at first pregnancy.

Authors:  A B Miller; T H Barclay; N W Choi; M G Grace; C Wall; M Plante; G R Howe; B Cinader; F G Davis
Journal:  J Chronic Dis       Date:  1980

3.  Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma.

Authors:  D Trichopoulos; N E Day; E Kaklamani; A Tzonou; N Muñoz; X Zavitsanos; Y Koumantaki; A Trichopoulou
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

4.  Oral contraceptives and hepatocellular carcinoma.

Authors:  J Neuberger; D Forman; R Doll; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

5.  Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case/control study in South African black women.

Authors:  M C Kew; E Song; A Mohammed; J Hodkinson
Journal:  Hepatology       Date:  1990-02       Impact factor: 17.425

6.  Risk factors for hepatocellular carcinoma in Catalonia, Spain.

Authors:  M V Mayans; X Calvet; J Bruix; M Bruguera; J Costa; J Estève; F X Bosch; C Bru; J Rodés
Journal:  Int J Cancer       Date:  1990-09-15       Impact factor: 7.396

7.  Oral contraceptive use and liver cancer.

Authors:  J R Palmer; L Rosenberg; D W Kaufman; M E Warshauer; P Stolley; S Shapiro
Journal:  Am J Epidemiol       Date:  1989-11       Impact factor: 4.897

8.  Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.

Authors:  E Kaklamani; D Trichopoulos; A Tzonou; X Zavitsanos; Y Koumantaki; A Hatzakis; C C Hsieh; S Hatziyannis
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

9.  Combined oral contraceptives and liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Authors: 
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

10.  Oral contraceptives and primary liver cancer.

Authors:  C La Vecchia; E Negri; F Parazzini
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more
  4 in total

1.  Mortality from cancers of the digestive system among grand multiparous women in Taiwan.

Authors:  Brian K Chen; Chun-Yuh Yang
Journal:  Int J Environ Res Public Health       Date:  2014-04-22       Impact factor: 3.390

2.  Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project.

Authors:  K A McGlynn; V V Sahasrabuddhe; P T Campbell; B I Graubard; J Chen; L M Schwartz; J L Petrick; M C Alavanja; G Andreotti; D A Boggs; J E Buring; A T Chan; N D Freedman; S M Gapstur; A R Hollenbeck; L Hou; L Y King; J Koshiol; M Linet; J R Palmer; J N Poynter; M Purdue; K Robien; C Schairer; H D Sesso; A Sigurdson; J Wactawski-Wende; A Zeleniuch-Jacquotte
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

3.  Female hormone utilisation and risk of hepatocellular carcinoma.

Authors:  A Tavani; E Negri; F Parazzini; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

4.  Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.

Authors:  H Tanaka; T Hiyama; H Tsukuma; I Fujimoto; H Yamano; Y Okubo; A Kitada
Journal:  Jpn J Cancer Res       Date:  1994-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.